Cwm, LLC Recursion Pharmaceuticals, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 7,783 shares of RXRX stock, worth $56,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,783

Previous 6,245 24.63%

Holding current value

$56,348

Previous $47,000 8.51%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$5.92 - $8.6 $9,104 - $13,226	1,538 Added 24.63%	7,783 $51,000
Q2 2024 Jul 09, 2024	BUY	$7.35 - $10.05 $139 - $190	19 Added 0.31%	6,245 $47,000
Q4 2023 Feb 01, 2024	BUY	$5.09 - $10.79 $213 - $453	42 Added 0.68%	6,226 $61,000
Q2 2023 Aug 03, 2023	BUY	$4.56 - $9.94 $177 - $387	39 Added 0.63%	6,184 $46,000
Q1 2023 Apr 28, 2023	BUY	$6.42 - $9.64 $37,467 - $56,259	5,836 Added 1888.67%	6,145 $41,000
Q4 2022 Feb 01, 2023	SELL	$7.16 - $12.7 $62,155 - $110,248	-8,681 Reduced 96.56%	309 $2,000
Q3 2022 Oct 27, 2022	BUY	$7.83 - $13.6 $35,078 - $60,928	4,480 Added 99.33%	8,990 $96,000
Q2 2022 Jul 28, 2022	BUY	$5.04 - $9.26 $22,730 - $41,762	4,510 New	4,510 $37,000
Q1 2022 Apr 21, 2022	SELL	$6.16 - $18.03 $27,781 - $81,315	-4,510 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$16.14 - $21.86 $72,307 - $97,932	4,480 Added 14933.33%	4,510 $77,000
Q1 2021 Sep 15, 2021	BUY	N/A	30 New	30 $1,000
Q1 2021 Apr 27, 2021	SELL	N/A	-30 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	N/A	30 New	30 $1,000
Q4 2020 Jan 27, 2021	SELL	N/A	-30 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	N/A	30 New	30 $1,000
Q3 2020 Oct 19, 2020	SELL	N/A	-30 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	N/A	30 New	30 $1,000
Q2 2020 Jul 22, 2020	SELL	N/A	-30 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	N/A	30 New	30 $1,000
Q1 2020 Apr 28, 2020	SELL	N/A	-30 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	N/A	30 New	30 $1,000
Q4 2019 Jan 27, 2020	SELL	N/A	-30 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	N/A	30 New	30 $1,000
Q3 2019 Oct 22, 2019	SELL	N/A	-30 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	N/A	30 New	30 $1,000
Q2 2019 Jul 31, 2019	SELL	N/A	-30 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	N/A	30 New	30 $0

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account